Recombinant Human VEGF-D (carrier-free)

Product Details

Source

Human VEGF-D, amino acids (Phe89-Arg205) (Accession# O43915), was expressed in HEK293.

Molecular Mass

The 117 amino acid recombinant protein has a predicted molecular mass of approximately 13.1 kD. The protein migrates at approximately 20-22 kD under non-reducing conditions by SDS-PAGE. The predicted N-terminal amino acid is Phe.

Purity

>95%, as determined by SDS-PAGE gel and HPLC analysis.

Formulation

Lyophilized from 0.2 µm filtered protein solution in 10 mM Sodium Citrate, pH 4.0.

Endotoxin Level

Less than 1.0 EU per µg protein as determined by the LAL method.

Storage & Handling

Unopened vial can be stored at -20°C or -70°C. For maximum results, quick spin vial prior to opening. Reconstitute in water to a concentration of 0.1-0.5 mg/ml. Do not vortex. It is recommended to further dilute in a buffer containing a carrier protein such as 0.1% BSA and store working aliquots at -20°C to -80°C. Avoid repeated freeze/thaw cycles.

Activity

ED₅₀ = 0.15 — 0.6 µg/mL as measured by the ability of the protein to induce proliferation of HMVEC.

Application

Bioassay

Antigen Details

Structure

Non-covalent homodimer.

Distribution

VEGF-D is expressed in the adult lungs, heart, muscles, and small intestines; it is most abundantly expressed in the fetal heart and lungs and skin.

Function

VEGF-D plays a key role in lymphangiogenesis, stimulates the migration, proliferation, and the survival of human endothelial cells.

Interaction

Lymphatic endothelial cells and vascular endothelial cells.

Ligand/Receptor

VEGF-R3, VEGF-R2, and Neuropilin-1.

Bioactivity

Measured by the ability of humanVEGF-D to induce the proliferation of HMVEC human microvascular endothelial cells.

Cell Type

Neural Stem Cells, Mesenchymal Stem Cells, Hematopoietic stem and progenitors

Biology Area

Cell Biology, Neuroscience, Stem Cells, Synaptic Biology, Angiogenesis, Stem Cells

Molecular Family

Growth Factors, Cytokines/Chemokines

Antigen References

1. Yamada Y, et al. 1997. Genomics 42:483-488.
2. Achen MG, et al. 1998. Proc. Natl. Acad. Sci. USA 2:548-553.
3. Stacker SA, et al. 2001. Nat. Med. 2:186-91.
4. Duff SE, et al. 2003. Br. J. Cancer 89:426-430.
5. Tammela T, et al.  2005. Cardiovasc. Res. 65:550-563.
6. Roy H, et al. 2006. FEBS Letters 580:2879-87.
7. Cui Y, et al. 2014. Mol. Med. 20:120-134.

Gene ID

2277 View all products for this Gene ID

UniProt

View information about VEGF-D on UniProt.org

Documentation

• Technical data sheet
• Certificate of Analysis
• Safety Data Sheet

Reviews

Related Pages & Pathways

Related FAQs

Why choose BioLegend recombinant proteins?

     • Each lot of product is quality-tested for bioactivity as indicated on the data sheet.
     • Greater than 95% Purity or higher, tested on every lot of product.
     • 100% Satisfaction Guarantee for quality performance, stability, and consistency.
     • Ready-to-use liquid format saves time and reduces challenges associated with reconstitution.
     • Bulk and customization available. Contact us.
     • Learn more about our Recombinant Proteins.

How does the activity of your recombinant proteins compare to competitors?

We quality control each and every lot of recombinant protein. Not only do we check its bioactivity, but we also compare it against other commercially available recombinant proteins. We make sure each recombinant protein’s activity is at least as good as or better than the competition’s. In order to provide you with the best possible product, we ensure that our testing process is rigorous and thorough. If you’re curious and eager to make the switch to BioLegend recombinants, contact your sales representative today!

What is the specific activity or ED50 of my recombinant protein?

The specific activity range of the protein is indicated on the product datasheets. Because the exact activity values on a per unit basis can largely fluctuate depending on a number of factors, including the nature of the assay, cell density, age of cells/passage number, culture media used, and end user technique, the specific activity is best defined as a range and we guarantee the specific activity of all our lots will be within the range indicated on the datasheet. Please note this only applies to recombinants labeled for use in bioassays. ELISA standard recombinant proteins are not recommended for bioassay usage as they are not tested for these applications.

Have your recombinants been tested for stability?

Our testing shows that the recombinant proteins are able to withstand room temperature for a week without losing activity. In addition the recombinant proteins were also found to withstand four cycles of freeze and thaw without losing activity.

Does specific activity of a recombinant protein vary between lots?

Specific activity will vary for each lot and for the type of experiment that is done to validate it, but all passed lots will have activity within the established ED50 range for the product and we guarantee that our products will have lot-to-lot consistency. Please conduct an experiment-specific validation to find the optimal ED50 for your system.

How do you convert activity as an ED50 in ng/ml to a specific activity in Units/mg?

Use formula Specific activity (Units/mg) = 10^6/ ED50 (ng/mL)

Certificate of Analysis